These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 12602080)

  • 1. The health economics of calcium and vitamin D3 for the prevention of osteoporotic hip fractures in Sweden.
    Willis MS
    Int J Technol Assess Health Care; 2002; 18(4):791-807. PubMed ID: 12602080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of a fixed dose combination of alendronate and cholecalciferol in the treatment and prevention of osteoporosis in the United Kingdom and The Netherlands.
    Jansen JP; Gaugris S; Bergman G; Sen SS
    Curr Med Res Opin; 2008 Mar; 24(3):671-84. PubMed ID: 18221588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Denosumab: a cost-effective alternative for older men with osteoporosis from a Swedish payer perspective.
    Parthan A; Kruse M; Agodoa I; Silverman S; Orwoll E
    Bone; 2014 Feb; 59():105-13. PubMed ID: 24231131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium-vitamin D3 supplementation is cost-effective in hip fractures prevention.
    Lilliu H; Pamphile R; Chapuy MC; Schulten J; Arlot M; Meunier PJ
    Maturitas; 2003 Apr; 44(4):299-305. PubMed ID: 12697371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health-economic comparison of three recommended drugs for the treatment of osteoporosis.
    Brecht JG; Kruse HP; Möhrke W; Oestreich A; Huppertz E
    Int J Clin Pharmacol Res; 2004; 24(1):1-10. PubMed ID: 15575171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost effectiveness of ibandronate for the prevention of fractures in inflammatory bowel disease-related osteoporosis: cost-utility analysis using a Markov model.
    Kreck S; Klaus J; Leidl R; von Tirpitz C; Konnopka A; Matschinger H; König HH
    Pharmacoeconomics; 2008; 26(4):311-28. PubMed ID: 18370566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin K supplementation for the primary prevention of osteoporotic fractures: is it cost-effective and is future research warranted?
    Gajic-Veljanoski O; Bayoumi AM; Tomlinson G; Khan K; Cheung AM
    Osteoporos Int; 2012 Nov; 23(11):2681-92. PubMed ID: 22398856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness analysis of hip fracture prevention with vitamin D supplementation: a Markov micro-simulation model applied to the French population over 65 years old without previous hip fracture.
    Zarca K; Durand-Zaleski I; Roux C; Souberbielle JC; Schott AM; Thomas T; Fardellone P; Benhamou CL
    Osteoporos Int; 2014 Jun; 25(6):1797-806. PubMed ID: 24691648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Supplemental calcium for the prevention of hip fracture: potential health-economic benefits.
    Bendich A; Leader S; Muhuri P
    Clin Ther; 1999 Jun; 21(6):1058-72. PubMed ID: 10440627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of fracture prevention treatments in the elderly.
    Fleurence RL
    Int J Technol Assess Health Care; 2004; 20(2):184-91. PubMed ID: 15209178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intervention thresholds for osteoporosis in men and women: a study based on data from Sweden.
    Kanis JA; Johnell O; Oden A; Borgstrom F; Johansson H; De Laet C; Jönsson B
    Osteoporos Int; 2005 Jan; 16(1):6-14. PubMed ID: 15103452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using economics to prioritize research: a case study of randomized trials for the prevention of hip fractures due to osteoporosis.
    Torgerson D; Donaldson C; Reid D
    J Health Serv Res Policy; 1996 Jul; 1(3):141-6. PubMed ID: 10180860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacoeconomic analysis of osteoporosis treatment with risedronate.
    Brecht JG; Kruse HP; Felsenberg D; Möhrke W; Oestreich A; Huppertz E
    Int J Clin Pharmacol Res; 2003; 23(4):93-105. PubMed ID: 15224498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost effectiveness of alendronate (fosamax) for the treatment of osteoporosis and prevention of fractures.
    Johnell O; Jönsson B; Jönsson L; Black D
    Pharmacoeconomics; 2003; 21(5):305-14. PubMed ID: 12627984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of vitamin D and calcium supplementation in the treatment of elderly women and men with osteoporosis.
    Hiligsmann M; Ben Sedrine W; Bruyère O; Evers SM; Rabenda V; Reginster JY
    Eur J Public Health; 2015 Feb; 25(1):20-5. PubMed ID: 25096255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effective osteoporosis treatment thresholds in Greece.
    Makras P; Athanasakis K; Boubouchairopoulou N; Rizou S; Anastasilakis AD; Kyriopoulos J; Lyritis GP
    Osteoporos Int; 2015 Jul; 26(7):1949-57. PubMed ID: 25740208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Economic evaluation of osteoporosis liaison service for secondary fracture prevention in postmenopausal osteoporosis patients with previous hip fracture in Japan.
    Moriwaki K; Noto S
    Osteoporos Int; 2017 Feb; 28(2):621-632. PubMed ID: 27699441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A coordinator program in post-fracture osteoporosis management improves outcomes and saves costs.
    Sander B; Elliot-Gibson V; Beaton DE; Bogoch ER; Maetzel A
    J Bone Joint Surg Am; 2008 Jun; 90(6):1197-205. PubMed ID: 18519311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost effectiveness of alendronate for the treatment of male osteoporosis in Sweden.
    Borgström F; Johnell O; Jönsson B; Zethraeus N; Sen SS
    Bone; 2004 Jun; 34(6):1064-71. PubMed ID: 15193554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What is the impact of daily oral supplementation of vitamin D3 (cholecalciferol) plus calcium on the incidence of hip fracture in older people? A systematic review and meta-analysis.
    Manoj P; Derwin R; George S
    Int J Older People Nurs; 2023 Jan; 18(1):e12492. PubMed ID: 35842938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.